Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2225 of 2228 entries
View as:

Safety of Nintedanib in Real World in China

Phase: N/A Priority: Normal
NCT ID: NCT05676112 Org: User:
Start: 12/29/23 End: 09/30/26 Due: 09/30/27

BI 44370 TA in Acute Migraine Attack

Phase: N/A Priority: Normal
NCT ID: NCT00751803 Org: User:
Start: 08/31/08 End: - Due: -

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02224105 Org: User:
Start: 03/31/10 End: - Due: -

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03659136 Org: User:
Start: 11/28/18 End: 05/11/22 Due: 05/11/23

Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization

Phase: N/A Priority: Normal
NCT ID: NCT05395351 Org: User:
Start: 11/30/22 End: 03/28/23 Due: 03/28/24

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04762277 Org: User:
Start: 04/06/21 End: 04/21/22 Due: 04/21/23

Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01284621 Org: User:
Start: 01/31/11 End: - Due: -

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Phase: N/A Priority: Normal
NCT ID: NCT02239120 Org: User:
Start: 11/27/14 End: 08/14/18 Due: 08/14/19

Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183181 Org: User:
Start: 11/30/08 End: - Due: -

Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194348 Org: User:
Start: 02/29/00 End: - Due: -

Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00274092 Org: User:
Start: 09/30/02 End: 10/31/03 Due: 10/31/04

Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate

Phase: N/A Priority: Normal
NCT ID: NCT02171624 Org: User:
Start: 03/31/09 End: - Due: -

Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

Phase: N/A Priority: Normal
NCT ID: NCT02191215 Org: User:
Start: 06/30/03 End: - Due: -

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Phase: N/A Priority: Normal
NCT ID: NCT00054717 Org: User:
Start: 01/31/03 End: - Due: -

Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02184286 Org: User:
Start: 05/31/99 End: - Due: -

A Study in Healthy Men to Test How BI 1569912 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT06520553 Org: User:
Start: 08/26/24 End: 10/03/24 Due: 10/03/25

Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00875433 Org: User:
Start: 03/31/09 End: - Due: -

LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Phase: N/A Priority: Normal
NCT ID: NCT01085136 Org: User:
Start: 02/28/10 End: 01/31/16 Due: 01/31/17

Impact of Tiotropium Add-on Therapy in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03964220 Org: User:
Start: 03/15/19 End: 09/20/19 Due: 09/20/20

Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04795245 Org: User:
Start: 08/26/21 End: 10/16/23 Due: 10/16/24

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03313180 Org: User:
Start: 11/27/17 End: 01/25/23 Due: 01/25/24

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT02204072 Org: User:
Start: 11/11/14 End: 06/01/23 Due: 06/01/24

Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria

Phase: N/A Priority: Normal
NCT ID: NCT00558467 Org: User:
Start: 01/31/08 End: - Due: -

Safety of Single Rising Doses and Relative Bioavailability of BI 691751

Phase: N/A Priority: Normal
NCT ID: NCT01843972 Org: User:
Start: 04/30/13 End: 11/30/13 Due: 11/30/14

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05741385 Org: User:
Start: 10/10/23 End: 08/23/24 Due: 08/23/25